Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:
• Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization
• Patients for whom consent can be obtained
Locations
Other Locations
Japan
Kyoto University Hospital
RECRUITING
Kyoto
Contact Information
Primary
Takeshi Kimura, MD, PhD
taketaka@kuhp.kyoto-u.ac.jp
+81-75-751-4255
Backup
Erika Yamamoto, MD, PhD
erkymmt@kuhp.kyoto-u.ac.jp
+81-75-751-4255
Time Frame
Start Date: 2022-06-14
Estimated Completion Date: 2030-12
Participants
Target number of participants: 2890
Treatments
Active_comparator: Aspirin
Aspirin 100 mg/day
Active_comparator: No Aspirin
No Aspirin
Related Therapeutic Areas
Sponsors
Leads: Takeshi Morimoto